Works Cited

1. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009–2010.J Rent Des. 2012;91:914-920.

2. Dumitrescu AL, Inagaki K. Occlusal considerations in pathogenesis of periodontal disease. In: Dumitrescu AL (ed). Etiology and Pathogenesis of Periodontal Disease. Norway: Springer; 2010: 295-306.

3. Merck Manuals Online Medical Library. Periodontitis. Available at Last accessed December 6, 2016.

4. Okuda K. Bacteriological diagnosis of periodontal disease. Bull Tokyo Dent Coll. 1994;35(3):107-119.

5. Socransky SS. Microbiology of periodontal disease-present status and future considerations. J Periodontol. 1977;48(9):497-504.

6. Cobb CM. Microbes, inflammation, scaling and root planing, and the periodontal condition. J Dent Hyg. 2008;82(suppl 3):4-9.

7. Sauvetre E. Bacteriological aspects of periodontal disease. Rev Belge Med Dent. 1994;49(2):9-17.

8. Gorr SU. Antimicrobial peptides in periodontal innate defense. In: Kinane DF, Mombelli A (eds). Periodontal Disease. 15th ed. Basel: Karger; 2012: 84-98.

9. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134-144.

10. Paquette DW, Ryan ME, Wilder RS. Locally delivered antimicrobials: clinical evidence and relevance. J Dent Hyg. 2008;82(suppl 3):10-15.

11. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology. 1997;14:216-248.

12. Scannapieco FA, Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998;69(7):841-850.

13. Teng YT, Taylor GW, Scannapieco F, et al. Periodontal health and systemic disorders. J Can Dent Assoc. 2002;68(3)188-192.

14. Rose LF, Steinberg BJ, Minsk L. The relationship between periodontal disease and systemic conditions. Compend Contin Educ Dent. 2000;21(10A):870-877.

15. Anil S, Al-Ghamdi HS. The impact of periodontal infections on systemic disease: an update for medical practitioners. Saudi Med J. 2006;27(6):767-776.

16. Ford PJ, Raphael SL, Cullinan MP, Jenkins AJ, West MJ, Seymour GJ. Why should a doctor be interested in oral disease? Expert Rev Cardiovasc Ther. 2010;8(10):1483-1493.

17. Mealey BL, Oates TW. AAP commissioned review: diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289-1303.

18. Research, Science and Therapy Committee of the American Academy of Periodontology. position paper: tobacco use and the periodontal patient. J Periodontol. 1999;70:1419-1427.

19. Hellden LB, Listgarten MA, Lindhe J. The effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol. 1979;6(4):222-230.

20. Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. J Periodontol. 1979;50(10):495-509.

21. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy: a review of the literature. J Periodontol. 1996;67(11):1143-1158.

22. Walker C. The supplemental use of antibiotics in periodontal therapy. Compend Contin Educ Dent. 1999;20(4):4-12.

23. Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: systemic antibiotics in periodontics. J Periodontol. 2004;75(11):1553-1565.

24. Greenstein G, Tonetti M, Research, Science and Therapy Committee of the American Academy of Periodontology. The role of controlled drug delivery for periodontitis. J Periodontol. 2000;71(1):125-140.

25. Bathla S. Periodontics Revisited. India: Jaypee; 2011.

26. HealthPartners Dental Group and Clinics. Guidelines for the Diagnosis and Treatment of Periodontal Diseases. Minneapolis, MN: HealthPartners; 2011.

27. Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: diagnosis of periodontal diseases. J Periodontol. 2003;74:1237-1247.

28. Sweeting LA, Davis K, Cobb CM. Periodontal treatment protocol (PTP) for the general dental practice. J Dent Hyg. 2008;82(suppl 3):16-26.

29. American Academy of Periodontology. Parameter on comprehensive periodontal examination. J Periodontol. 2000;71(suppl 5): 847-848.

30. Wiebe CB, Putnins EE. The periodontal disease classification system of the American Academy of Periodontology: an update.J Can Dent Assoc. 2000;66(11):594-597.

31. Prichard J. The role of the roentgenogram in the diagnosis and prognosis of periodontal disease. Oral Surg Oral Med Oral Pathol. 1961;14(2):182-196.

32. Robinson PJ, Vitek RM. The relationship between gingival inflammation and resistance to probe penetration. J Periodontal Res. 1979;14(3):239-243.

33. Khan S, Cabanilla LL. Periodontal probing depth measurement: a review. Compend Contin Educ Dent. 2009;30(1):12-14, 16, 18-21, 36.

34. National Institute of Dental and Craniofacial Research. Development of Technologies for Saliva/Oral Fluid Based Diagnostics. Available at Last accessed December 6, 2016.

35. National Institute of Dental and Craniofacial Research. Salivary Diagnostic Device Shows Promise. Available at Last accessed December 6, 2016.

36. Munjal S, Miethe P, Netuschil L, Struck F, Maier K, Bauermeister C. Immunoassay-based diagnostic point-of-care technology for oral specimen. Ann N Y Acad Sci. 2007;1098:486-489.

37. Herr AE, Hatch AV, Giannobile WV, et al. Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci. 2007;1098:362-374.

38. Prescher N, Maier K, Munjal SK, et al. Rapid quantitative chairside test for active MMP-8 in gingival crevicular fluid: first clinical data. Ann N Y Acad Sci. 2007;1098:493-495.

39. Mäntylä P, Stenman M, Kinane DF, et al. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res. 2003;38(4):436-439.

40. Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc. 2006;137(3):313-321.

41. Abrams WR, Barber CA, McCann K, et al. Development of a microfluidic device for detection of pathogens in oral samples using upconverting phosphor technology (UPT). Ann N Y Acad Sci. 2007;1098:375-388.

42. Christodoulides N, Mohanty S, Miller CS, et al. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip. 2005;5(3):261-269.

43. Campbell L, Keene S. A look at periodontal disease, the contrasting referral approaches of general dentists to periodontal specialists and how it affects the duties and ethics of dental hygienists. Internet J Dent Sci. 2009;7:2.

44. Trieger N. The surgical treatment of periodontal infections. Oral Maxillofac Surg Clin North Am. 2003;15(1):123-128.

45. Hardy JH, Newman HN, Strahan JD. Direct irrigation and subgingival plaque. J Clin Periodontol. 1982;9(1):57-65.

46. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322-332.

47. Armitage GC. Basic features of biofilms: why are they difficult therapeutic targets? Ann R Australas Coll Dent Surg. 2004;17:30-34.

48. Iqbal Z, Jain N, Jain GK, et al. Dental therapeutic systems. Recent Pat Drug Deliv Formul. 2008;2(1):58-67.

49. American Dental Association. CDT Current Dental Terminology. Chicago, IL: American Dental Association; 2017.

50. Goodson JM, Haffajee A, Socransky SS. Periodontal therapy by local delivery of tetracycline. J Clin Periodontol. 1979;6(2):83-92.

51. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol. 1983;54(10):575-579.

52. Kornman KS. Controlled-release local delivery antimicrobials in periodontics: prospects for the future. J Periodontol. 1993;64(8):782-791.

53. Dental Board of California. Title 16, Professional and Vocational Regulations. Division 10. Dental Board of California. Chapter 3. Dental Auxiliaries. Article 5. Duties and Settings. Section 1088. RDH Duties and Settings. Available at Last accessed December 6, 2016.

54. LexiComp Online. Available at Last accessed December 6, 2016.

55. DailyMed. Available at Last accessed December 6, 2016.

56. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 22nd ed. Hudson, OH: Lexi-Comp, Inc.; 2016.

57. Vogel S. Chairside Salivary Diagnostics for Oral Diseases. Available at Last accessed December 6, 2016.

58. Jeffcoat MK, Bray KS, Ciancio SG, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol. 1998;69(9):989-997.

59. Paolantonio M, D'Angelo M, Grassi RF, et al. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study. J Periodontol. 2008;79(2):271-282.

60. Ciancio SG. Local delivery of chlorhexidine. Compend Contin Educ Dent. 1999;20(5):427-432.

61. Soskolne WA, Heasman PA, Stabholz A, et al. Sustained local delivery of chlorhexidine in the treatment of periodontitis: a multi-center study. J Periodontol. 1997;68(1):32-38.

62. Carvalho J, Novak MJ, Mota LF. Evaluation of the effect of subgingival placement of chlorhexidine chips as an adjunct to scaling and root planing. J Periodontol. 2007;78(6):997-1001.

63. Cosyn J, Wyn I. A systematic review on the effects of the chlorhexidine chip when used as an adjunct to scaling and root planing in the treatment of chronic periodontitis. J Periodontol. 2006;77(2):257-264.

64. U.S. Food and Drug Administration. Atridox: Label Information. Available at Last accessed December .

65. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva and serum. J Periodontol. 1998;69(10):1085-1091.

66. Garrett S, Johnson L, Drisko CH, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol. 1999;70(5):490-503.

67. Garrett S, Adams DF, Bogle G, et al. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J Periodontol. 2000;71(1):22-30.

68. Walker CB, Godowski KC, Borden L, et al. The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva. J Periodontol. 2000;71(5):768-774.

69. Arestin Professional. ARESTIN Delivers Therapeutic Levels of Antibiotic with a Microsphere Delivery System. Available at Last accessed December 6, 2016.

70. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol. 2001;72(11):1535-1544.

71. Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: treatment of plaque-induced gingivitis, chronic periodontitis, and other clinical conditions. J Periodontol. 2001;72:1790-1800.

72. Task Force on Local Delivery of Antimicrobials as Adjunct Therapy. American Academy of Periodontology statement on local delivery of sustained or controlled release antimicrobials as adjunctive therapy in the treatment of periodontitis. J Periodontol. 2006;77:1458.

73. Hussein I, Ranka M, Gilbert A, Davey K. Locally delivered antimicrobials in the management of periodontitis: a critical review of the evidence for their use in practice. Dent Update. 2007;34(8):494-496, 499-502, 505-506.

74. American Academy of Periodontology. Parameter on chronic periodontitis with advanced loss of periodontal support. J Periodontol. 2000;71:856-858.

75. American Academy of Periodontology. Parameter on chronic periodontitis with slight to moderate loss of periodontal support.J Periodontol. 2000;71:853-855.

76. Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol. 2005;76(8):1227-1236.

77. Greenstein G. Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. J Am Dent Assoc. 2003;134:583-591.

78. Greenstein G, Lamster I. Efficacy of periodontal therapy: statistical versus clinical significance. J Periodontol. 2000;71(4):657-662.

79. American Academy of Periodontology. Parameter on aggressive periodontitis. J Periodontol. 2000;71(Suppl 5):867-869.

80. Stenman J, Hallberg U, Wennstrom JL, Abrahamsson KH. Patients' attitudes towards oral health and experiences of periodontal treatment: a qualitative interview study. Oral Health Prev Dent. 2009;7(4):393-401.

81. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontology. 2000;34:9-21.

82. American Academy of Periodontology. Parameter on periodontal maintenance. J Periodontol. 2000;71:849-850.

83. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.

84. Hellstrom MK, McClain PK, Schallhorn RG, Bellis L, Hanlon AL, Ramberg P. Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis. J Clin Periodontol. 2008;35(6):525-531.

85. Silva-Senem MX, Heller D, Varela VM, Torres MCB, Feres-Filho EJ, Colombo APV. Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial. J Clin Periodontol. 2013;40(3):242-251.

86. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dent Res J (Isfahan). 2012;9(5):505-515.

87. Priyanka N, Kalra N, Shanbhag N, et al. Recent approaches in saliva as a credible periodontal diagnostic and prognostic marker. Arch Oral Sci Res. 2012;22(1):40-46.

88. Kondreddy K, Ambalavanan N, Ramakrishna T, Kumar RS. Effectiveness of a controlled-release chlorhexidine chip (PerioCol-CG) as an adjunctive to scaling and root planing when compared to scaling and root planing alone in the treatment of chronic periodontitis: a comparative study. J Indian Soc Periodontol. 2012;16(4):553-557.

89. OraPharma, Inc. ARESTIN (Minocycline Hydrochloride) Microspheres, 1 mg: Prescribing Information. Horsham, PA: OraPharma, Inc.; 2011.

90. Jung DY, Park JC, Kim YT, et al. The clinical effect of locally delivered minocycline in association with flap surgery for the treatment of chronic severe periodontitis: a split-mouth design. J Clin Periodontol. 2012;39(8):753-759.

Privacy Policy
Copyright © 2017 CE Resource, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.